AAAAAA

   
Results: 1-8 |
Results: 8
EXTRAVASCULAR ADMINISTRATION OF FACTOR-IX - POTENTIAL FOR REPLACEMENTTHERAPY OF CANINE AND HUMAN HEMOPHILIA-B
Authors: LILES D LANDEN CN MONROE DM LINDLEY CM READ MS ROBERTS HR BRINKHOUS KM
Citation: D. Liles et al., EXTRAVASCULAR ADMINISTRATION OF FACTOR-IX - POTENTIAL FOR REPLACEMENTTHERAPY OF CANINE AND HUMAN HEMOPHILIA-B, Thrombosis and haemostasis, 77(5), 1997, pp. 944-948
GENE-THERAPY FOR HEMOPHILIA-B - HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION
Authors: FANG B EISENSMITH RC WANG H KAY MA CROSS RE LANDEN CN GORDON G BELLINGER DA READ MS HU PC BRINKHOUS KM WOO SLC
Citation: B. Fang et al., GENE-THERAPY FOR HEMOPHILIA-B - HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION, Human gene therapy, 6(8), 1995, pp. 1039-1044
GENE-THERAPY FOR HEMOPHILIA-B - HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED GENE-TRANSFER
Authors: FANG B EISENSMITH RC WANG H KAY MA CROSS RE LANDEN CN GAVIN G BELLINGER DA READ MS HU PC BRINKHOUS KM WOO SLC
Citation: B. Fang et al., GENE-THERAPY FOR HEMOPHILIA-B - HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED GENE-TRANSFER, Journal of cellular biochemistry, 1995, pp. 363-363
EXTRAVASCULAR ADMINISTRATION OF FACTOR-IX - PROSPECTS FOR GENE-THERAPY OF HEMOPHILIA
Authors: LILES DK MONROE DM BRINKHOUS KM READ MS LANDEN CN ROBERTS HR
Citation: Dk. Liles et al., EXTRAVASCULAR ADMINISTRATION OF FACTOR-IX - PROSPECTS FOR GENE-THERAPY OF HEMOPHILIA, Thrombosis and haemostasis, 73(6), 1995, pp. 1420-1420
IN-VIVO HEPATIC GENE-THERAPY - COMPLETE ALBEIT TRANSIENT CORRECTION OF FACTOR-IX DEFICIENCY IN HEMOPHILIA-B DOGS
Authors: KAY MA LANDEN CN ROTHENBERG SR TAYLOR LA LELAND F WIEHLE S FANG BL BELLINGER D FINEGOLD M THOMPSON AR READ M BRINKHOUS KM WOO SLC
Citation: Ma. Kay et al., IN-VIVO HEPATIC GENE-THERAPY - COMPLETE ALBEIT TRANSIENT CORRECTION OF FACTOR-IX DEFICIENCY IN HEMOPHILIA-B DOGS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(6), 1994, pp. 2353-2357
GENE-THERAPY FOR HEMOPHILIA-B - CYCLOSPORINE TREATMENT INCREASES THE PERSISTENCE OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION IN HEMOPHILIA-B DOGS
Authors: EISENSMITH RC FANG B KAY MA LANDEN CN CROSS RE BELLINGER DA READ MS HU PC BRINKHOUS KM WOO SLC
Citation: Rc. Eisensmith et al., GENE-THERAPY FOR HEMOPHILIA-B - CYCLOSPORINE TREATMENT INCREASES THE PERSISTENCE OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION IN HEMOPHILIA-B DOGS, Blood, 84(10), 1994, pp. 10000255-10000255
IN-VIVO GENE-THERAPY OF HEMOPHILIA-B - SUSTAINED PARTIAL CORRECTION IN FACTOR-IX-DEFICIENT DOGS
Authors: KAY MA ROTHENBERG S LANDEN CN BELLINGER DA LELAND F TOMAN C FINEGOLD M THOMPSON AR READ MS BRINKHOUS KM WOO SLC
Citation: Ma. Kay et al., IN-VIVO GENE-THERAPY OF HEMOPHILIA-B - SUSTAINED PARTIAL CORRECTION IN FACTOR-IX-DEFICIENT DOGS, Science, 262(5130), 1993, pp. 117-119
EVALUATION OF SENSITIVITY OF WHOLE-BLOOD CLOTTING TIME (WBCT), PARTIAL THROMBOPLASTIN TIME (PTT), AND F.IX ONE-STAGE BIOASSAY TESTS WITH LOW PLASMA F.IX LEVELS OBSERVED WITH TRANSFUSION OR GENE-THERAPY IN CANINE HEMOPHILIA-B
Authors: BRINKHOUS KM LANDEN CN READ MS
Citation: Km. Brinkhous et al., EVALUATION OF SENSITIVITY OF WHOLE-BLOOD CLOTTING TIME (WBCT), PARTIAL THROMBOPLASTIN TIME (PTT), AND F.IX ONE-STAGE BIOASSAY TESTS WITH LOW PLASMA F.IX LEVELS OBSERVED WITH TRANSFUSION OR GENE-THERAPY IN CANINE HEMOPHILIA-B, Blood, 82(10), 1993, pp. 10000592-10000592
Risultati: 1-8 |